Atomoxetine, sold under the brand name Strattera, is an FDA-approved medication for treating attention-deficit/hyperactivity disorder (ADHD). It is approved for both children (ages 6 and older) and adults, making it one of the few non-stimulant options available across the full age spectrum of ADHD treatment.
How Atomoxetine Treats ADHD
Atomoxetine works by blocking the reabsorption of norepinephrine, a brain chemical involved in attention, impulse control, and focus. By keeping more norepinephrine available between nerve cells, the medication helps improve the core symptoms of ADHD: inattention, hyperactivity, and impulsivity.
This mechanism is different from stimulant medications like methylphenidate or amphetamines, which primarily increase dopamine activity. That distinction matters for several reasons, especially when it comes to abuse potential and who the medication is appropriate for.
Why It’s Chosen Over Stimulants
The biggest practical difference between atomoxetine and stimulant ADHD medications is that atomoxetine has no meaningful abuse potential. In studies comparing it to methylphenidate in people who recreationally use drugs, atomoxetine was not rated as pleasurable and produced no euphoria. Participants liked it no more than a placebo. Methylphenidate and other stimulants, by contrast, produced typical “high” effects and were rated significantly more appealing.
Because of this, atomoxetine is not classified as a controlled substance. Stimulant ADHD medications are Schedule II drugs, the same category as oxycodone, which means prescriptions often come with tighter refill restrictions and more frequent office visits. Atomoxetine prescriptions can typically be called in or sent electronically and written with refills, making the logistics simpler for patients and families.
This profile makes atomoxetine a particularly good fit for people with a history of substance use, those in environments where stimulant diversion is a concern (such as college campuses), or anyone who prefers to avoid controlled substances. It also provides steady, around-the-clock symptom coverage rather than the peaks and valleys that some people experience with short-acting stimulants.
How Long It Takes to Work
One of the most important things to know about atomoxetine is that it works slowly compared to stimulants. You may notice some improvement during the first week, but the full therapeutic effect typically takes up to a month. This is a significant difference from stimulant medications, which usually produce noticeable effects within an hour of the first dose.
This slower onset can be frustrating, and it’s a common reason people abandon the medication too early. If you’re starting atomoxetine, it helps to set realistic expectations. The dose is also increased gradually: treatment begins at a lower dose and is raised after a minimum of three days, with further adjustments possible over the following weeks. For adults and adolescents over 70 kg, the starting dose is 40 mg daily, with a typical target of 80 mg and a maximum of 100 mg. For smaller children, dosing is based on body weight.
Common Side Effects
Side effects differ somewhat between children and adults. In children and teenagers, the most frequently reported effects are upset stomach, decreased appetite, nausea or vomiting, dizziness, tiredness, and mood swings. Adults tend to experience constipation, dry mouth, nausea, decreased appetite, dizziness, trouble sleeping, sexual side effects, and difficulty urinating.
Appetite suppression is one of the more consistent effects across age groups. For growing children, this is something worth tracking, as weight and height should be monitored over time. Many of these side effects are most pronounced in the first few weeks and ease as the body adjusts.
Serious Risks to Be Aware Of
Atomoxetine carries an FDA black box warning related to suicidal thinking in children and adolescents. This doesn’t mean the medication causes suicide, but clinical data showed a small increase in suicidal thoughts in younger patients during early treatment. Families should watch for unusual changes in mood or behavior, particularly in the first few months or after dose changes.
There is also a rare but serious risk of liver injury. No liver damage was detected in clinical trials involving roughly 6,000 patients, but postmarketing reports have documented rare cases of significant liver problems, including one case that required a liver transplant. Routine liver testing is not required, but you should be alert to warning signs: yellowing of the skin or eyes, dark urine, unexplained itching, pain in the upper right abdomen, or flu-like symptoms that don’t have an obvious cause. If any of these appear, the medication should be stopped and liver function tested.
Other Potential Uses
While ADHD is the only FDA-approved indication, atomoxetine has been explored for other purposes. Research from the University of Pennsylvania found that it may improve attention and reduce memory difficulties in perimenopausal and postmenopausal women, a group that often experiences cognitive changes related to hormonal shifts. These uses remain off-label, meaning they haven’t gone through the full FDA approval process for those specific conditions, but they reflect the medication’s core action on attention-related brain chemistry.
What Daily Treatment Looks Like
Atomoxetine is taken as a capsule, either once in the morning or split into two doses (morning and late afternoon). Unlike stimulants, which wear off in hours, it provides continuous coverage throughout the day and into the evening. This can be an advantage for people who struggle with ADHD symptoms during homework time, evening routines, or early morning hours before a stimulant would kick in.
Because the medication builds up in your system over weeks rather than working dose by dose, consistency matters. Skipping days will reduce its effectiveness more than skipping a single dose of a stimulant would. If it’s working well, most people stay on it long-term, though the decision to continue is revisited periodically based on how symptoms are managed and whether side effects remain tolerable.